title: The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence.
authors.affiliation: 2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ddumitrascu@umfcluj.ro.
authors.forename: Dan L
authors.initials: DL
authors.lastname: Dumitrascu
authors.affiliation: 2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Chira
authors.affiliation: University of Medicine and Pharmacy, Tg-Mures, Romania.
authors.forename: Simona
authors.initials: S
authors.lastname: Bataga
authors.affiliation: Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania.
authors.forename: Mircea
authors.initials: M
authors.lastname: Diculescu
authors.affiliation: Gr. T. Popa University of Medicine and Pharmacy, Institute of Gastroenterology and Hepatology, Iasi, Romania.
authors.forename: Vasile
authors.initials: V
authors.lastname: Drug
authors.affiliation: Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania.
authors.forename: Cristian
authors.initials: C
authors.lastname: Gheorghe
authors.affiliation: Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Timisoara, Romania.
authors.forename: Adrian
authors.initials: A
authors.lastname: Goldis
authors.affiliation: Department of Internal Medicine, Transilvania University, Brasov, Romania.
authors.forename: Laurentiu
authors.initials: L
authors.lastname: Nedelcu
authors.affiliation: Lucian Blaga University, Sibiu, Romania.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Porr
authors.affiliation: Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Timisoara, Romania.
authors.forename: Ioan
authors.initials: I
authors.lastname: Sporea
mesh_terms: D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine / Q000592:standards; D005762:Gastroenterology / Q000592:standards*; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D010627:Phenethylamines / Q000009:adverse effects / Q000627:therapeutic use*; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D010627:Phenethylamines; C005096:mebeverine